Warning: The NCBI web site requires JavaScript to function. more...
Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.
Zheng YH, Peterlin BM.
Retrovirology. 2005 Apr 13;2:25. Review.
Related citations
APOBEC3 proteins and reverse transcription.
Aguiar RS, Peterlin BM.
Virus Res. 2008 Jun;134(1-2):74-85. Epub 2008 Feb 11. Review.
Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.
Huthoff H, Towers GJ.
Trends Microbiol. 2008 Dec;16(12):612-9. Epub 2008 Oct 29. Review.
Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.
Goffinet C, Michel N, Allespach I, Tervo HM, Hermann V, Kräusslich HG, Greene WC, Keppler OT.
Retrovirology. 2007 Jul 26;4:53.
Interaction between HIV-1 and APOBEC3 sub-family of proteins.
Arriaga ME, Carr J, Li P, Wang B, Saksena NK.
Curr HIV Res. 2006 Oct;4(4):401-9. Review.
HIV-1 Vif, APOBEC, and intrinsic immunity.
Goila-Gaur R, Strebel K.
Retrovirology. 2008 Jun 24;5:51. Review.
Dynamics of virus-host interplay in HIV-1 replication.
Sorin M, Kalpana GV.
Curr HIV Res. 2006 Apr;4(2):117-30. Review.
Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins.
Virgen CA, Hatziioannou T.
J Virol. 2007 Dec;81(24):13932-7. Epub 2007 Oct 17.
APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y, Wang X, Dang Y, Zheng YH.
PLoS Pathog. 2008 Jul 4;4(7):e1000095.
Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration.
Tervo HM, Goffinet C, Keppler OT.
Retrovirology. 2008 Jul 8;5:58.
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN, Holmes RK, Malim MH.
J Virol. 2006 Sep;80(17):8450-8.
A unified concept of HIV latency.
Bagasra O.
Expert Opin Biol Ther. 2006 Nov;6(11):1135-49. Review.
Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.
Yang Y, Guo F, Cen S, Kleiman L.
Virology. 2007 Aug 15;365(1):92-100. Epub 2007 Apr 24.
Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.
Sakuma R, Mael AA, Ikeda Y.
J Virol. 2007 Sep;81(18):10201-6. Epub 2007 Jul 3.
N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC, Tian YJ, Ding HH, Wang BJ, Yang Y, Hao YH, Zhao XP, Lu MJ, Gong FL, Yang DL.
World J Gastroenterol. 2006 Dec 14;12(46):7488-96.
Early stages of HIV replication: how to hijack cellular functions for a successful infection.
Lehmann-Che J, Saïb A.
AIDS Rev. 2004 Oct-Dec;6(4):199-207. Review.
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
Holmes RK, Koning FA, Bishop KN, Malim MH.
J Biol Chem. 2007 Jan 26;282(4):2587-95. Epub 2006 Nov 22.
Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue.
Anderson J, Akkina R.
Hum Gene Ther. 2008 Mar;19(3):217-28.
HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O, Babu J, Di Santo R, McColl DJ, Weber J, Quiñones-Mateu M.
AIDS Rev. 2008 Jul-Sep;10(3):172-89. Review.
Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.
Tsurutani N, Yasuda J, Yamamoto N, Choi BI, Kadoki M, Iwakura Y.
J Virol. 2007 Jan;81(2):677-88. Epub 2006 Nov 1.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on